AI Summary
Thinking
We reviewed 3 live results for ihc antibody and narrowed them down to the 3 options that look most worth comparing first.
The options are Preclinical Histology & IHC Services, IHC Kits and Reagents and Myositis-Specific 11 Antibody Panel.
Source: Champions Oncology
Description
Champions Oncology provides comprehensive preclinical histology and immunohistochemistry (IHC) services to support oncology research and drug development. Offerings include tissue collection, processing, FFPE generation, H&E staining, biomarker optimization, custom tumor tissue microarrays (TMAs), and quantitative slide digitization. Supported by board-certified pathologists and GCLP-compliant laboratories, these services deliver high-quality target expression analysis and histopathology endpoints for PDX models, in vivo and ex vivo studies, and clinical trial sample evaluation.
Best for
Oncology researchers, Preclinical drug development teams, Evaluating target biomarker expression in tumor tissues and Selecting and analyzing PDX and TumorGraft models
Rate this product
Source: Danaher Life Sciences
Description
Danaher Life Sciences offers a comprehensive portfolio of immunohistochemistry (IHC) kits, reagents, antibodies, and sample preparation tools designed for precision and reproducibility in tissue staining. The range includes recombinant monoclonal primary antibodies, conjugated secondary antibodies, antigen retrieval buffers, blocking serums, and detection systems such as Labeled Streptavidin-Biotin (LSAB) ABC and EXPOSE micro-polymer kits. Supporting single-, double-, and triple-staining protocols, these solutions enable simultaneous multi-antigen detection across neuroscience, oncology, and pathological research applications.
Best for
Life science researchers, Pathologists, Immunohistochemistry tissue staining and Multiplex antigen detection
Rate this product
Source: Mito Health
Description
Myositis-Specific 11 Antibody Panel by Mito Health is a specialized diagnostic blood test designed to identify inflammatory muscle disease subtypes, including polymyositis and dermatomyositis. The panel analyzes eleven autoantibodies—EJ, Jo-1, MDA5, Mi-2 alpha, Mi-2 beta, MJ, OJ, PL-12, PL-7, SRP, and TIF1-gamma—to assess muscle inflammation, associated skin manifestations, and interstitial lung disease involvement. Testing is fulfilled via blood draw at CLIA/CAP-accredited partner laboratories across forty-seven US states and Washington, DC, with clinician-reviewed results delivered digitally.
Best for
Individuals experiencing progressive proximal muscle weakness, Patients with dermatomyositis skin signs or unexplained interstitial lung disease, Confirming and subtyping inflammatory myopathy and Investigating autoimmune causes of elevated muscle enzymes
Rate this product
| Compare | #1Preclinical Histology & IHC Services | #2IHC Kits and Reagents | #3Myositis-Specific 11 Antibody Panel |
|---|---|---|---|
| Source | Champions Oncology | Danaher Life Sciences | Mito Health |
| Description | Champions Oncology provides comprehensive preclinical histology and immunohistochemistry (IHC) services to support oncology research and drug development. Offerings include tissue collection, processing, FFPE generation, H&E staining, biomarker optimization, custom tumor tissue microarrays (TMAs), and quantitative slide digitization. Supported by board-certified pathologists and GCLP-compliant laboratories, these services deliver high-quality target expression analysis and histopathology endpoints for PDX models, in vivo and ex vivo studies, and clinical trial sample evaluation. | Danaher Life Sciences offers a comprehensive portfolio of immunohistochemistry (IHC) kits, reagents, antibodies, and sample preparation tools designed for precision and reproducibility in tissue staining. The range includes recombinant monoclonal primary antibodies, conjugated secondary antibodies, antigen retrieval buffers, blocking serums, and detection systems such as Labeled Streptavidin-Biotin (LSAB) ABC and EXPOSE micro-polymer kits. Supporting single-, double-, and triple-staining protocols, these solutions enable simultaneous multi-antigen detection across neuroscience, oncology, and pathological research applications. | Myositis-Specific 11 Antibody Panel by Mito Health is a specialized diagnostic blood test designed to identify inflammatory muscle disease subtypes, including polymyositis and dermatomyositis. The panel analyzes eleven autoantibodies—EJ, Jo-1, MDA5, Mi-2 alpha, Mi-2 beta, MJ, OJ, PL-12, PL-7, SRP, and TIF1-gamma—to assess muscle inflammation, associated skin manifestations, and interstitial lung disease involvement. Testing is fulfilled via blood draw at CLIA/CAP-accredited partner laboratories across forty-seven US states and Washington, DC, with clinician-reviewed results delivered digitally. |
| Best for | Oncology researchers, Preclinical drug development teams, Evaluating target biomarker expression in tumor tissues and Selecting and analyzing PDX and TumorGraft models | Life science researchers, Pathologists, Immunohistochemistry tissue staining and Multiplex antigen detection | Individuals experiencing progressive proximal muscle weakness, Patients with dermatomyositis skin signs or unexplained interstitial lung disease, Confirming and subtyping inflammatory myopathy and Investigating autoimmune causes of elevated muscle enzymes |
| Action | Champions Oncology | Danaher Life Sciences | Mito Health |
| Rate this product |
"Preclinical Histology & IHC Services from Champions Oncology."
Note: TopFind AI compiles product and service information for general comparison purposes only.